Tsukasa Oda

Maebashi, 3718514, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Prognostic significance of inflammatory cytokine polymorphisms in AML: a study of IFNG, TNFA, and IL1B polymorphisms.

Prognostic significance of inflammatory cytokine polymorphisms in AML: a study of IFNG, TNFA, and IL1B polymorphisms.

Journal: BMC immunology
Published: November 25, 2025

Impact of inflammatory cytokine polymorphisms on the progression of myelodysplastic syndromes.

Impact of inflammatory cytokine polymorphisms on the progression of myelodysplastic syndromes.

Journal: Annals of hematology
Published: June 11, 2025

Mucin-dependent transcriptional dynamics of Akkermansia muciniphila in co-culture with human colonic organoids.

Mucin-dependent transcriptional dynamics of Akkermansia muciniphila in co-culture with human colonic organoids.

Journal: Bioscience, biotechnology, and biochemistry
Published: May 30, 2025

Role of Rac1 in p53-Related Proliferation and Drug Sensitivity in Multiple Myeloma.

Role of Rac1 in p53-Related Proliferation and Drug Sensitivity in Multiple Myeloma.

Journal: Cancers
Published: December 26, 2024

Comprehensive gene expression analysis of organoid-derived healthy human colonic epithelium and cancer cell line stimulated with live probiotic bacteria.

Comprehensive gene expression analysis of organoid-derived healthy human colonic epithelium and cancer cell line stimulated with live probiotic bacteria.

Journal: Scientific reports
Published: September 26, 2024

APEX1 Polymorphisms Affect Acute Myeloid Leukemia Risk, and Its Expression Is Involved in Cell Proliferation and Differentiation.

APEX1 Polymorphisms Affect Acute Myeloid Leukemia Risk, and Its Expression Is Involved in Cell Proliferation and Differentiation.

Journal: International journal of laboratory hematology
Published: May 23, 2024

Myeloma Microenvironmental TIMP1 Induces the Invasive Phenotype in Fibroblasts to Modulate Disease Progression.

Myeloma Microenvironmental TIMP1 Induces the Invasive Phenotype in Fibroblasts to Modulate Disease Progression.

Journal: International journal of molecular sciences
Published: December 16, 2022

Sub-lethal doses of chemotherapeutic agents induce senescence in T cells and upregulation of PD-1 expression.

Sub-lethal doses of chemotherapeutic agents induce senescence in T cells and upregulation of PD-1 expression.

Journal: Clinical and experimental medicine
Published: September 13, 2022

MYC Causes Multiple Myeloma Progression via Attenuating TP53-Induced MicroRNA-34 Expression.

MYC Causes Multiple Myeloma Progression via Attenuating TP53-Induced MicroRNA-34 Expression.

Journal: Genes
Published: August 05, 2022

DNA damage-induced cellular senescence is regulated by 53BP1 accumulation in the nuclear foci and phase separation.

DNA damage-induced cellular senescence is regulated by 53BP1 accumulation in the nuclear foci and phase separation.

Journal: Cell proliferation
Published: May 26, 2022

DNA Damage Response in Multiple Myeloma: The Role of the Tumor Microenvironment.

DNA Damage Response in Multiple Myeloma: The Role of the Tumor Microenvironment.

Journal: Cancers
Published: December 14, 2020

IDO2 rs10109853 polymorphism affects the susceptibility to multiple myeloma.

IDO2 rs10109853 polymorphism affects the susceptibility to multiple myeloma.

Journal: Clinical and experimental medicine
Published: November 18, 2020
Showing 1-12 of 21

Last Updated: 09/26/2026